INS and type 2 diabetes mellitus: The overview of glucose‐lowering drug treatment in type 2 diabetes revealed the proportion receiving insulin therapy increased preceding the hypoglycaemic event, possibly implying an intensified treatment in some of these individuals and implies good monitoring is important following intensified pharmaceutical therapy.